In addition, several research studies have revealed abnormal HCP5 expression that correlates with the prognosis of many cancers, making it a potential prognostic biomarker (Liu et al., 2019; Yang et al., 2019; Gao et al., 2021). The gene discussed is HCP5; the disease is cancer.